5322962025-01-012025-03-315322962025-03-315322962025-01-012025-03-31CompositionOfBoardOfDirectors15322962025-03-31CompositionOfBoardOfDirectors15322962025-01-012025-03-31CompositionOfBoardOfDirectors25322962025-03-31CompositionOfBoardOfDirectors25322962025-01-012025-03-31CompositionOfBoardOfDirectors35322962025-03-31CompositionOfBoardOfDirectors35322962025-01-012025-03-31CompositionOfBoardOfDirectors45322962025-03-31CompositionOfBoardOfDirectors45322962025-01-012025-03-31CompositionOfBoardOfDirectors55322962025-03-31CompositionOfBoardOfDirectors55322962025-01-012025-03-31CompositionOfBoardOfDirectors65322962025-03-31CompositionOfBoardOfDirectors65322962025-01-012025-03-31CompositionOfBoardOfDirectors75322962025-03-31CompositionOfBoardOfDirectors75322962025-01-012025-03-31CompositionOfBoardOfDirectors85322962025-03-31CompositionOfBoardOfDirectors85322962025-01-012025-03-31CompositionOfBoardOfDirectors95322962025-03-31CompositionOfBoardOfDirectors95322962025-01-012025-03-31CompositionOfCommittees145322962025-03-31CompositionOfCommittees145322962025-01-012025-03-31CompositionOfCommittees155322962025-03-31CompositionOfCommittees155322962025-01-012025-03-31CompositionOfCommittees165322962025-03-31CompositionOfCommittees165322962025-01-012025-03-31CompositionOfCommittees415322962025-03-31CompositionOfCommittees415322962025-01-012025-03-31CompositionOfCommittees425322962025-03-31CompositionOfCommittees425322962025-01-012025-03-31CompositionOfCommittees435322962025-03-31CompositionOfCommittees435322962025-01-012025-03-31CompositionOfCommittees685322962025-03-31CompositionOfCommittees685322962025-01-012025-03-31CompositionOfCommittees695322962025-03-31CompositionOfCommittees695322962025-01-012025-03-31CompositionOfCommittees705322962025-03-31CompositionOfCommittees705322962025-01-012025-03-31CompositionOfCommittees955322962025-03-31CompositionOfCommittees955322962025-01-012025-03-31CompositionOfCommittees965322962025-03-31CompositionOfCommittees965322962025-01-012025-03-31CompositionOfCommittees975322962025-03-31CompositionOfCommittees975322962025-01-012025-03-31CompositionOfCommittees985322962025-03-31CompositionOfCommittees985322962025-01-012025-03-31CompositionOfCommittees1225322962025-03-31CompositionOfCommittees1225322962025-01-012025-03-31CompositionOfCommittees1235322962025-03-31CompositionOfCommittees1235322962025-01-012025-03-31CompositionOfCommittees1245322962025-03-31CompositionOfCommittees1245322962025-01-012025-03-31CompositionOfCommittees1255322962025-03-31CompositionOfCommittees1255322962025-03-31MeetingOfBoardOfDirectors15322962025-01-012025-03-31MeetingOfBoardOfDirectors15322962025-03-31MeetingOfBoardOfDirectors25322962025-01-012025-03-31MeetingOfBoardOfDirectors25322962025-01-012025-03-31MeetingOfCommittees15322962025-03-31MeetingOfCommittees15322962025-01-012025-03-31MeetingOfCommittees25322962025-03-31MeetingOfCommittees25322962025-01-012025-03-31MeetingOfCommittees35322962025-03-31MeetingOfCommittees35322962025-01-012025-03-31MeetingOfCommittees45322962025-03-31MeetingOfCommittees45322962025-01-012025-03-31MeetingOfCommittees55322962025-03-31MeetingOfCommittees55322962025-01-012025-03-31MeetingOfCommittees65322962025-03-31MeetingOfCommittees65322962025-01-012025-03-31MeetingOfCommittees75322962025-03-31MeetingOfCommittees75322962025-01-012025-03-31MeetingOfCommittees85322962025-03-31MeetingOfCommittees85322962025-01-012025-03-31MeetingOfCommittees95322962025-03-31MeetingOfCommittees95322962025-01-012025-03-31MeetingOfCommittees105322962025-03-31MeetingOfCommittees105322962024-12-315322962025-03-31OngoingTaxLitigationsOrDisputesDomain1xbrli:pure532296GLENMARKNOTLISTEDINE935A01035Glenmark Pharmaceuticals Limited2024-04-012025-03-31Yearly2025-03-31EquitytruetruefalseAs per proviso of sub-para 1 of Para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has not made any acquisition during the quarter ended March 31, 2025.falseNo fine or penalty was imposed on the Company, in terms of sub-para 20 of Para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 during the quarter ended March 31, 2025.truefalseThe Company has not provided any loans (or other form of debt), guarantees, comfort letters (by whatever name called) or securities in connection with any loan(s) (or other form of debt) directly or indirectly to the promoter(s), promoter group, director(s) (including their relatives), key managerial personnel (including their relatives) or any entity controlled by them are in the economic interest of the company. Hence, the same is not applicable.trueTop 500 listed entitiestrueg00100OriginalMr. Pradeep Kumar Sinha was appointed as an Additional Director designated as Non-Executive - Independent, by the Board of Directors at their meeting held on 14th February, 2025. truetrueMrsBLANCHE SALDANHA00007671Non-Executive - Non Independent DirectorNot Applicable1940-07-04falseActiveYes2023-09-292009-08-142023-09-291000MrGLENN SALDANHAAMWPS4972P00050607Executive DirectorChairperson related to PromoterCEO-MD1969-11-26falseActiveNA1998-10-122022-05-161000MrsCHERYLANN PINTO00111844Executive DirectorNot Applicable1967-01-16falseActiveNA2007-05-162022-05-161010MrRAJESH V DESAIACOPD2684H00007960Non-Executive - Independent DirectorNot Applicable1958-07-14falseActiveNA2002-05-162020-06-26571122MrV.S. MANI01082878Executive DirectorNot Applicable1964-10-20falseActiveNA2018-05-292023-05-291000MsSONA SAIRA RAMASASTRYEHNPR8176L08398547Non-Executive - Independent DirectorNot Applicable1975-10-28falseActiveNA2019-04-012024-04-01721120MrDIPANKAR BHATTACHARJEE08770548Non-Executive - Independent DirectorNot Applicable1960-11-02falseActiveNA2020-08-142020-08-14561100MrsVIJAYALAKSHMI RAJARAM IYERAAHPI7741P05242960Non-Executive - Independent DirectorNot Applicable1955-06-01falseActiveNA2023-02-102023-02-10265593MrPRADEEP KUMAR SINHA00145126Non-Executive - Independent DirectorNot Applicable1955-07-18falseActiveNA2025-02-142025-02-1422200The Board at their meeting held on 14th February,2025 approved reconstitution of the Committes with effect from 15th February, 2025. The committees of the Board have been re-constituted as under: 1. Audit Committee - Mrs. Vijayalakshmi Rajaram Iyer was appointed as Chairperson and Mr. Rajesh V Desai was appointed as Member. 2. Risk Management Committee - Mr. Dipankar Bhattacharjee was appointed as Chairperson and Mr. Glenn Saldanha was appointed as Member. 3. Corporate Social Responsibility Committee - Mr. Rajesh V Desai ceased to be a member and Mr. Pradeep Kumar Sinha was appointed as Member. truetruetruetruetrueAudit Committee05242960VIJAYALAKSHMI RAJARAM IYERNon-Executive - Independent DirectorChairperson2025-02-15Audit Committee00007960RAJESH V DESAINon-Executive - Independent DirectorMember2025-02-15Audit Committee08398547SONA SAIRA RAMASASTRYNon-Executive - Independent DirectorMember2024-04-01Nomination and remuneration committee08770548DIPANKAR BHATTACHARJEENon-Executive - Independent DirectorChairperson2024-04-01Nomination and remuneration committee00050607GLENN SALDANHAExecutive DirectorMember1999-12-31Nomination and remuneration committee05242960VIJAYALAKSHMI RAJARAM IYERNon-Executive - Independent DirectorMember2024-04-01Stakeholders Relationship Committee00007960RAJESH V DESAINon-Executive - Independent DirectorChairperson2024-04-01Stakeholders Relationship Committee00111844CHERYLANN PINTOExecutive DirectorMember2009-01-27Stakeholders Relationship Committee08398547SONA SAIRA RAMASASTRYNon-Executive - Independent DirectorMember2020-06-26Risk Management Committee08770548DIPANKAR BHATTACHARJEENon-Executive - Independent DirectorChairperson2025-02-15Risk Management Committee00007960RAJESH V DESAINon-Executive - Independent DirectorMember2014-10-30Risk Management Committee00050607GLENN SALDANHAExecutive DirectorMember2025-02-15Risk Management Committee01082878V.S. MANIExecutive DirectorMember2019-02-14Corporate Social Responsibility Committee00111844CHERYLANN PINTOExecutive DirectorChairperson2013-05-07Corporate Social Responsibility Committee05242960VIJAYALAKSHMI RAJARAM IYERNon-Executive - Independent DirectorMember2024-04-01Corporate Social Responsibility Committee00145126PRADEEP KUMAR SINHANon-Executive - Independent DirectorMember2025-02-15Corporate Social Responsibility Committee00007960RAJESH V DESAINon-Executive - Independent DirectorMember2014-07-242025-02-142024-11-14true8842025-02-1491true995Audit Committee2024-11-13true3330Audit Committee2025-02-1391true3330Nomination and remuneration committee2024-11-13true3320Nomination and remuneration committee2025-02-1391true3320Stakeholders Relationship Committee2024-11-13true3320Stakeholders Relationship Committee2025-02-1391true3320Risk Management Committee2024-11-14true4420Risk Management Committee2025-02-1491true4420Corporate Social Responsibility Committee2024-11-12true3320Corporate Social Responsibility Committee2025-02-1392true3320truetruetruetrueYestruetruetrueHarish KuberCompany Secretary and Compliance OfficerYeshttps://glenmarkpharma.com/about-us/evolution/Yeshttps://glenmarkpharma.com/investors/memorandum-article-of-association/Yeshttps://glenmarkpharma.com/about-us/board-of-directors/Yeshttps://glenmark.b-cdn.net/gpl_pdfs/about_us/Information-related-to-independent-directors.pdfYeshttps://glenmarkpharma.com/about-us/governance/Yeshttps://glenmarkpharma.com/code-of-conduct/Yeshttps://glenmark.b-cdn.net/gpl_pdfs/about_us/Whistleblowing%20Policy.pdfYeshttps://glenmark.b-cdn.net/gpl_pdfs/investors/reports_presentations/Criteria%20of%20payment%20to%20NEDs.pdfYeshttps://glenmark.b-cdn.net/gpl_pdfs/about_us/Policy%20on%20RPT%20and%20its%20Materiality.pdfYeshttps://glenmark.b-cdn.net/gpl_pdfs/about_us/Policy%20for%20Determining%20Material%20Subsidiaries2024.pdfYeshttps://glenmark.b-cdn.net/gpl_pdfs/investors/disclosure/Details%20of%20Familiarization%20programmes.pdfYeshttps://glenmark.b-cdn.net/gpl_pdfs/about_us/Contact%20information%20for%20investor%20grievances.pdfYeshttps://glenmark.b-cdn.net/gpl_pdfs/about_us/Contact%20information%20for%20investor%20grievances.pdfYeshttps://glenmarkpharma.com/investors/results-sheet/Yeshttps://glenmarkpharma.com/investors/shareholders-corner/shareholding-pattern/NAYeshttps://glenmarkpharma.com/investors/reports-presentations/investors-presentations/Yeshttps://glenmarkpharma.com/investors/reports-presentations/earnings-concall/NAYeshttps://glenmarkpharma.com/investors/shareholders-corner/information-in-the-newspaper/Yeshttps://glenmark.b-cdn.net/gpl_pdfs/investors/disclosure/Credit%20Ratings%20new.pdfYeshttps://glenmarkpharma.com/investors/reports-presentations/subsidiary-financials/subsidiary-financials-2023-24/Yeshttps://glenmarkpharma.com/investors/shareholders-corner/annual-secretarial-compliance-report/Yeshttps://glenmark.b-cdn.net/gpl_pdfs/about_us/Policy%20on%20Determination%20of%20Materiality%20for%20Disclosures2024.pdfYeshttps://glenmark.b-cdn.net/gpl_pdfs/about_us/Policy%20on%20Determination%20of%20Materiality%20for%20Disclosures2024.pdfYeshttps://glenmarkpharma.com/investors/NAYeshttps://glenmark.b-cdn.net/gpl_pdfs/about_us/Dividend%20Distribution%20Policy.pdfYeshttps://glenmarkpharma.com/investors/reports-presentations/annual-return/Yeshttps://glenmarkpharma.com/about_us/ESOS%20Scheme_2016.pdfYeshttps://glenmarkpharma.com/Yeshttps://glenmarkpharma.com/disclosure-under-regulation-46-of-sebi/YesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesNAYesYesYesNAYesYesYesYesYesYesYesYesYesYesYesYesHarish KuberCompany Secretary and Compliance OfficerYesHarish KuberCompany Secretary and Compliance OfficerfalseHarish KuberCompany Secretary and Compliance OfficerMumbai2025-04-3000000Joint Commissioner of CGST & CX Palghar, Maharashtra2025-02-04Order passed under relevant provisions of the Central Goods and Services Tax Act, 2017 for the period 2017-18 to 2021-22 raising following demand: 1. Rs.57,69,73,678/- on account of excess IGST Refund claimed on CIF value instead of FOB value; 2. Appropriating Rs.5,85,79,174/- already paid by company on account of surrender of IGST refunds towards non realization of export proceed. 3. Applicable interest on the above amounts; 4. Rs.63,55,52,852/- towards penalty equivalent to the above tax amounts.Ongoing